|
Mechanism5-HT receptor agonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Taiwan Province |
First Approval Date31 Dec 1995 |
100 Clinical Results associated with Cenra, Inc.
0 Patents (Medical) associated with Cenra, Inc.
100 Deals associated with Cenra, Inc.
100 Translational Medicine associated with Cenra, Inc.